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CASE REPORT
Solitary Type of Congenital Self-healing 
Reticulohistiocytosis
Gantsetseg Dorjsuren, M.D., Hee Jung Kim, M.D., Jin Young Jung, M.D., Byung Gi Bae, M.D., 
Ju Hee Lee, M.D., Ph.D.
Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea
Congenital self-healing reticulohistiocytosis is a rare, con-
genital, benign, self-healing variant of Langerhans cell histio-
cytosis. It usually appears as multiple papules or nodules; 
however, occurrence of the solitary type is very rare. We 
report on a case of solitary congenital self-healing reticulo-
histiocytosis in a 29-day-old girl who presented with a papule 
on her sole. Two months later, the lesion regressed with a 
slight scar. Based upon clinical and histologic findings, we 
made a diagnosis of solitary congenital self-healing reticulo-
histiocytosis. In this report, we summarized reported cases of 
solitary congenital self-healing retioculohistiocytosis in Korea 
with a review of the literature. (Ann Dermatol 23(S1) S4∼S7, 
2011)
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INTRODUCTION
Langerhans cell histiocytosis (LCH) is a disease of dysre-
gulated proliferation of Langerhans cells with subsequent 
organ involvement. Congenital self-healing reticulohis-
tiocytosis (CSHRH) is a congenital variant of LCH, which 
does not show systemic involvement1. Clinical presen-
tation typically consists of multiple papules or nodules, 
which show spontaneous involution within a few months. 
Due to its poorly specific clinical features and self-limiting 
character, solitary CSHRH is much rarer and difficult to 
diagnose. Since it is prone to be confused with other 
dermatologic tumor conditions, dermatologists should have 
an understanding of the clinical and histologic findings.
In Korea, just two cases of solitary CSHRH have been 
reported2,3. Herein, we report on an additional case of so-
litary CSHRH.
CASE REPORT 
A 29-day-old girl presented with a solitary skin colored 
papule with crust on her left sole since birth. She was 
delivered at term by vaginal delivery following a normal 
pregnancy to a primipara primigravida mother. Overall, 
she was healthy, without perinatal problems. There was 
no Ed-highlight-Please review.
Family history. Physical examination revealed a dome- 
shaped, skin colored papule measuring 7 mm, with crust, 
on her left sole (Fig. 1A). However, no organomegaly or 
superficial palpable lymph nodes were observed. Clinical 
diagnoses, including hemangioma, juvenile xanthogra-
nuloma, and congenital self-healing reticulohistiocytosis 
were made and skin biopsy was performed on the sole. 
Atrophic epidermis and effacement of rete ridges were 
observed (Fig. 2A). A dense infiltrate of histiocytic cells 
admixed with numerous eosinophils and some scattered 
lymphocytes were observed. No multinucleated giant cells 
were observed in our histologic section (Fig. 2B). His-
tiocytes had a large, vesicular, and some kidney- shaped 
nuclei with prominent nucleoli. On immunohistiochemical 
staining with CD1a and S-100, the majority of tumor cells 
showed strong reactivity (Fig. 3). Ultrastructural studies were
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Fig. 1. (A) A dome-shaped papule with
central crust measuring 7 mm on the
left sole. (B) Regressed lesion with scar
after 2 months.
Fig. 2. (A) Hematoxylin and eosin staining revealed atrophic epidermis, effacement of rete ridges, and a dense infiltrate of histiocytes 
admixed with numerous eosinophils and some lymphocytes (H&E, ×100). (B) Histiocytes showed a large, round, or reniform nuclei, 
with prominent nucleoli and eosinophilic ground glass cytoplasm (H&E, ×400).
Fig. 3. Strong S-100 protein (A) and CD1a (B) expressions are noted in the majority of tumor cells (Immunoperoxidase stain, ×200).
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Table 1. Summary of case series of solitary CSHRH reported in Korea
References Diagnosis/sex Lesiononset Location
Clinical 
apperance
Time to 
resolution
Systemic 
involvement Follow-up
Chun and 2 months/F Since birth Chin Pea-sized, erythematous papule with NA None NA
 Song2 (1992)  hemorrhagic crusts
Shin et al.3 1 day/M Since birth Lt heel 3 mm sized erythematous papule with 4 weeks None NA
 (2008)  central ulceration and yellowish crust
Present case 29 days/F Since birth Lt sole 7 mm sized, dome-shaped, and skin 2 months None 1 year
 colored papule with crust
NA: not available.
not performed. Laboratory studies, including complete 
blood count, coagulation profile, serum protein electro-
phoresis, chemical battery, urinalysis, VDRL, congenital 
infection studies (TORCH), and chest radiography were 
normal. Two months later, the lesion had completely 
regressed, leaving a scar (Fig. 1B). At 1 year after diagnosis, 
no recurrence or systemic involvement has been observed. 
Based upon clinical, histopathologic, and laboratory fin-
dings, a diagnosis of congenital self-healing reticulohis-
tiocytosis was made.
DISCUSSION
CSHRH, first described by Hashimoto-Pritzker in 1973, is 
a rare and self-limited form of LCH1. The disease is 
characterized by multiple papules or nodules, which have 
a tendency to show spontaneous regression. Lesions are 
usually multiple, but, more rarely, solitary. The first case 
of solitary CSHRH was reported by Berger et al.4 in 1986. 
Since then, several cases of a solitary form have been 
reported. Bernstein et al.5 reported that solitary CSHRH 
appeared to contribute to approximately 25% of CSHRH 
cases. However, this disease shows poorly specific clinical 
features and spontaneous regression within a few months; 
therefore, the real incidence of solitary CSHRH might be 
underreported6. Two cases of solitary CSHRH have been 
reported in Korea2,3. Reported cases are summarized in 
Table 1. 
Clinical manifestations of CSHRH are polymorphic, pre-
senting as papules, nodules, crusts, vesicles, and, rarely, 
hemorrhagic bullae, which can sometimes become ulce-
rated, necrotic, and crusted7-9. Lack of systemic involve-
ment, as well as spontaneous resolution of cutaneous 
lesions, are essential for a diagnosis of CSHRH. The 
lesions regress within a mean period of 15 weeks and 
recurrence has never been reported10. Histopathologi-
cally, there are dense intradermal infiltrations of histio-
cytes showing abundant eosinophilic cytoplasm and 
kidney-shaped or indented nuclei associated with lym-
phocytes and eosinophils. These histiocytes show strong 
expression of S-100 protein and CD1a, markers of Langer-
hans cells (LC)11,12. 
Differential diagnosis includes hemangioma, juvenile xan-
thogranuloma, Spitz nevi, mastocytoma, and histiocytic 
disorders. Those diseases can be differentiated by histopa-
thologic findings. In cases of juvenile xanthogranuloma, 
histiocytes can be differentiated with immunohistoche-
mical staining, such as S-100 protein and CD1a. Among 
histiocytic disorders, differentiation of indeterminate cell 
histiocytoma (ICH) from CSHRH is difficult. ICH is char-
acterized by positive immunohistochemical staining for 
S-100 protein and CD1a, but can be differentiated from 
CSHRH by absence of Birbeck granules13. Electron mi-
croscopic examination of CSHRH reveals Birbeck granules 
and laminated dense bodies in 10 to 25% of histiocytes14. 
In our case, we did not perform an electron microscopic 
examination, but made a diagnosis of CSHRH, since, ICH 
is much more rare than CSHRH, has tendency to occur in 
adults, and only a few cases have been reported as a 
solitary variant7,15. 
The pathogenesis of the self-limiting nature of CSHRH 
remains to be elucidated. Weiss et al.16 have studied 
various dendritic cell markers in CSHRH. With immuno-
histochemistry, tumor cells showed positive staining for 
S-100 protein, CD1a, and HLA-DR. However, tumor cells 
showed negative staining for Langerin and CD68. They 
speculated that CSHRH should be comprised of activated 
mature LCs, because CD68 expression is lost and Langerin 
staining is decreased in the process of LCs and dendritic 
cell maturation17,18. The authors explained the self- 
regressing character of CSHRH as the tumor cells of 
CSHRH eventually becoming apoptotic on terminal ma-
turation, which is the natural course of LC activation16.
No treatment is required for CSHRH; however, clinical 
and laboratory monitoring is mandatory. To date, there 
have been no reports of systemic involvement or com-
plications in solitary CSHRH. However, there has been 
one case of a girl with CSHRH, who had sparse skin 
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lesions resolving at 1 and 1/2 years of age, but developed 
diabetes insipidus at the age of 4 years19. Although, there 
is no evidence of an association of CSHRH with diabetes 
insipidus in that case, regular follow up will be important 
for management. Zunino-Goutorbe et al.11 recommended 
regular physical examination for at least 2 years. They pro-
posed performance of simple laboratory tests and radio-
graphs initially, with repetition of laboratory analyses, 
including inflammation, hepatic, and differential blood 
counts at 6 months, and imaging studies only if required 
by clinical manifestations. We are now following up the 
patient for one year; however, there is no evidence of 
systemic involvement and recurrence.
Herein, we report on an additional case of solitary 
CSHRH with a review of literature.
REFERENCES
1. Hashimoto K, Pritzker MS. Electron microscopic study of re-
ticulohistiocytoma. An unusual case of congenital, self- hea-
ling reticulohistiocytosis. Arch Dermatol 1973;107:263-270.
2. Chun SI, Song MS. Congenital self-healing reticulohistio-
cytosis-report of a case of the solitary type and review of the 
literature. Yonsei Med J 1992;33:194-198.
3. Shin MS, Park HJ, Choi YJ, Park MY. A case of solitary type 
of congenital self-healing reticulohistiocytosis. Korean J Der-
matol 2008;46:411-413.
4. Berger TG, Lane AT, Headington JT, Hartmann K, Burrish G, 
Levin MW, et al. A solitary variant of congenital self-healing 
reticulohistiocytosis: solitary Hashimoto-Pritzker disease. 
Pediatr Dermatol 1986;3:230-236.
5. Bernstein EF, Resnik KS, Loose JH, Halcin C, Kauh YC. So-
litary congenital self-healing reticulohistiocytosis. Br J Der-
matol 1993;129:449-454.
6. Kapur P, Erickson C, Rakheja D, Carder KR, Hoang MP. 
Congenital self-healing reticulohistiocytosis (Hashimoto- 
Pritzker disease): ten-year experience at Dallas children’s 
medical center. J Am Acad Dermatol 2007;56:290-294.
7. Jang KA, Ahn SJ, Choi JH, Sung KJ, Moon KC, Koh JK. 
Histiocytic disorders with spontaneous regression in infancy. 
Pediatr Dermatol 2000;17:364-368.
8. Higgins CR, Tatnall FM, Leigh IM. Vesicular Langerhans cell 
histiocytosis-an uncommon variant. Clin Exp Dermatol 1994; 
19:350-352.
9. Inuzuka M, Tomita K, Tokura Y, Takigawa M. Congenital 
self-healing reticulohistiocytosis presenting with hemorrha-
gic bullae. J Am Acad Dermatol 2003;48(5 Suppl):S75-S77.
10. Kanitakis J, Zambruno G, Schmitt D, Cambazard F, Jacque-
mier D, Thivolet J. Congenital self-healing histiocytosis (Has-
himoto-Pritzker). An ultrastructural and immunohistochemi-
cal study. Cancer 1988;61:508-516.
11. Zunino-Goutorbe C, Eschard C, Durlach A, Bernard P. 
Congenital solitary histiocytoma: a variant of Hashimoto- 
Pritzker histiocytosis. A retrospective study of 8 cases. Der-
matology 2008;216:118-124.
12. Zwerdling T, Konia T, Silverstein M. Congenital, single 
system, single site, Langerhans cell histiocytosis: a new case, 
observations from the literature, and management conside-
rations. Pediatr Dermatol 2009;26:121-126.
13. Saijo S, Hara M, Kuramoto Y, Tagami H. Generalized 
eruptive histiocytoma: a report of a variant case showing the 
presence of dermal indeterminate cells. J Cutan Pathol 
1991;18:134-136.
14. Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, 
Duncan MH, et al. Langerhans'-cell histiocytosis (histiocyto-
sis X)-a clonal proliferative disease. N Engl J Med 1994;331: 
154-160.
15. Sidoroff A, Zelger B, Steiner H, Smith N. Indeterminate cell 
histiocytosis--a clinicopathological entity with features of 
both X- and non-X histiocytosis. Br J Dermatol 1996;134: 
525-532.
16. Weiss T, Weber L, Scharffetter-Kochanek K, Weiss JM. 
Solitary cutaneous dendritic cell tumor in a child: role of 
dendritic cell markers for the diagnosis of skin Langerhans 
cell histiocytosis. J Am Acad Dermatol 2005;53:838-844.
17. Valladeau J, Duvert-Frances V, Pin JJ, Dezutter-Dambuyant 
C, Vincent C, Massacrier C, et al. The monoclonal antibody 
DCGM4 recognizes Langerin, a protein specific of Langer-
hans cells, and is rapidly internalized from the cell surface. 
Eur J Immunol 1999;29:2695-2704.
18. Geissmann F, Lepelletier Y, Fraitag S, Valladeau J, Bodemer 
C, Debré M, et al. Differentiation of Langerhans cells in 
Langerhans cell histiocytosis. Blood 2001;97:1241-1248.
19. Esterly NB, Maurer HS, Gonzalez-Crussi F. Histiocytosis X: a 
seven-year experience at a children's hospital. J Am Acad 
Dermatol 1985;15:481-496.
